Enveric Biosciences, Inc.

NasdaqCM:ENVB Stok Raporu

Piyasa değeri: US$4.4m

Enveric Biosciences Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Enveric Biosciences has a total shareholder equity of $5.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.1M and $645.3K respectively.

Anahtar bilgiler

0%

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranın/a
NakitUS$3.50m
EşitlikUS$5.41m
Toplam yükümlülüklerUS$645.34k
Toplam varlıklarUS$6.05m

Son finansal sağlık güncellemeleri

Recent updates

An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued

Jul 02
An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued

Enveric Biosciences to raise $8M in stock offering for corporate use

Jul 25

Enveric Biosciences Goes Psychedelic With MagicMed Acquisition

May 31

Enveric Biosciences announces $10M registered direct offering

Jan 12

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ENVB's short term assets ($5.5M) exceed its short term liabilities ($645.3K).

Uzun Vadeli Yükümlülükler: ENVB has no long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ENVB is debt free.

Borcun Azaltılması: ENVB currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: ENVB has less than a year of cash runway based on its current free cash flow.

Tahmini Nakit Akışı: ENVB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.9% each year


Sağlıklı şirketleri keşfedin